Zinger Key Points
- Elon Musk reportedly told an analyst if it’s a smooth year, Tesla has a potential to do 2 million cars.
- Intel's fourth-quarter revenue fell 32% year-over-year to $14 billion.
- Visa posted GAAP net income of $4.2 billion or $1.99 per share during the first quarter.
- Get New Picks of the Market's Top Stocks
U.S. markets surged on Thursday, following the release of fourth-quarter GDP data that came in better than expected. The U.S. economy grew by an estimated 2.9% in the last quarter of 2022 against economist expectations of 2.6% growth. The Nasdaq Composite and the S&P 500 rose over 1%, while the Dow gained 0.61%. Meanwhile, here are the five stocks that are drawing investors’ attention:
1. Tesla Inc TSLA: Shares of Tesla closed 10.97% higher on Thursday after the company reported better-than-expected fourth-quarter EPS and sales results. Fourth-quarter deliveries came in at 405,278, up 31% year-over-year. CEO Elon Musk told an analyst that if it’s a smooth year, without big supply chain interruptions or massive problems, Tesla has the potential to do 2 million cars this year for which there would be demand as well.
Also Read: How To Buy Intel (Intc) Stock
2. Intel Corporation INTC: Shares of Intel lost 9.27% during extended trading. The company said its fourth-quarter revenue fell 32% year-over-year to $14 billion, below analyst estimates of $14.49 billion. Full-year revenue was $63.1 billion, down 20% year-over-year.
3. Pfizer Inc. PFE: Shares of the company closed 0.92% lower on Thursday. Pfizer could see headwinds in 2023 due to declining COVID-19 cases, according to a UBS analyst. Colin Bristow downgraded Pfizer from ‘Buy’ to ‘Neutral’ and lowered the price target from $55 to $47.
4. Visa Inc V: Shares of Visa gained 1.25% in extended trading. The company posted a GAAP net income of $4.2 billion or $1.99 per share during the first quarter, recording an increase of 6% and 8%, respectively, over the prior year’s results.
5. Northrop Grumman Corp NOC: Shares of the company closed 4.28% lower on Thursday. It reported a fourth-quarter sales growth of 16% to $10.03 billion, beating the consensus of $9.66 billion. However, the company disclosed in an SEC filing that on Dec. 9, 2022, it received a criminal subpoena from the U.S. Department of Justice seeking information regarding financial and cost accounting and controls that appears focused on the interest rate.
Read Next: What's Going On With Bed Bath And Beyond's Stock Today?
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
